Earnings Alerts

Chemtrade Logistics Income Fund (CHE-U) Earnings: Q4 Net Income Falls Short Despite Revenue Growth

By February 28, 2025 No Comments
  • Chemtrade Logistics reported a net income of C$10.3 million for the fourth quarter, showing a 12% decrease compared to the previous year, and falling short of the estimated C$28.7 million.
  • Revenue for the quarter rose by 5.8% year-over-year to C$446.5 million, surpassing the estimate of C$413.3 million.
  • The company achieved an adjusted EBITDA of C$108.6 million, marking a notable 28% increase from the previous year, and exceeding the projected C$95.7 million.
  • Among analysts covering Chemtrade Logistics, there are 5 buy recommendations and 2 hold recommendations, with no sell recommendations.

A look at Chemtrade Logistics Income Fun Smart Scores

FactorScoreMagnitude
Value4
Dividend5
Growth5
Resilience2
Momentum3
OVERALL SMART SCORE3.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Chemtrade Logistics Income Fund is showing a promising long-term outlook according to Smartkarma Smart Scores. With strong scores in key areas such as dividend and growth, the company seems well-positioned for future success. The high scores in these factors indicate a solid performance in rewarding shareholders and potential for expansion.

However, there are some areas of concern highlighted by the Smart Scores, such as resilience and momentum. These lower scores suggest that the company may face challenges in terms of adaptability and maintaining a consistent growth trajectory. Despite these factors, Chemtrade Logistics Income Fund’s overall outlook appears positive, with a favourable balance of strengths that bode well for its future performance in the market.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars